PodBites
đ In this episode of PodBites, Lamar Antari and Leen Al-Fadhel take listeners into the world of antipsychotic pharmacology, using clinical stories and neuroscience principles to explain how these medications help manage schizophrenia and other psychotic disorders. đïž Tune in to explore: * The core symptom domains of schizophrenia â positive, negative, and cognitive symptoms * The dopamine hypothesis of schizophrenia and how imbalances in dopamine signaling contribute to psychosis * The four major dopamine pathways: mesolimbic, mesocortical, nigrostriatal, and tuberoinfundibular * How first-generation (typical) antipsychotics like haloperidol and chlorpromazine primarily work through Dâ receptor blockade * The major extrapyramidal side effects (EPS) including dystonia, akathisia, parkinsonism, and tardive dyskinesia * Important adverse effects such as hyperprolactinemia, orthostatic hypotension, sedation, and neuroleptic malignant syndrome * How second-generation (atypical) antipsychotics such as risperidone, quetiapine, aripiprazole, and clozapine target both dopamine and serotonin receptors * The trade-off between lower EPS risk but higher metabolic complications, including weight gain, insulin resistance, and dyslipidemia * Unique clinical features of key drugs like clozapine for treatment-resistant schizophrenia and the need for regular CBC monitoring due to agranulocytosis risk đ A high-yield, clinically grounded guide to understanding how antipsychotics affect brain pathways, improve symptoms of psychosis, and why balancing efficacy with side-effect management is essential in psychiatric pharmacotherapy.
100 episoder
Kommentarer
0VĂŠr den fĂžrste til at kommentere
Tilmeld dig nu og bliv en del af PodBites-fĂŠllesskabet!